Chemotherapy induced alopecia
Conditions
Interventions
Trial group (Sialo-OS ):The formulations will be applied topically to the scalp by subjects of the experimental respectively twice daily for 12 weeks.
Control group (placebo):The placebos will be applied topically to the scalp by subjects of the control groups respectively twice daily for 12 weeks.The placebo contains the extract of Tieguanyin tea,
Sponsors
Hong Kong Nang Yan College of Higher Education
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with chemotherapy-induced alopecia (within 3 months post-chemotherapy); 2. Scalp alopecia covering at least 30% of the scalp area, and; 3. Willingness to provide informed consent and adhere to the study protocol. 4. Voluntarily sign the informed consent form and comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1. Patients with other forms of alopecia (e.g., telogen effluvium, autoimmune diseases like lupus); 2. Scalp infections or dermatological conditions (e.g., psoriasis, eczema) that may interfere with hair regrowth; 3. Allergies to bird nest products or any ingredient in the formulation; 4. Use of other hair regrowth treatments (e.g., minoxidil, finasteride) within the past 3 months; 5. Use of other measures such as scalp cooling to prevent hair loss.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density (number of hairs/cm2) ;Hair thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Social Isolation;Appearance Anxiety;Body Image; | — |
Countries
China
Contacts
Public ContactProf. Thomas WONG
Hong Kong Nang Yan College of Higher Education
Outcome results
None listed